Senti Biosciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
SNTI Nasdaq 8731

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Senti Biosciences Inc

Here's Why Senti Biosciences (NASDAQ:SNTI) Must Use Its Cash Wisely - Jun 5th, 2023 12:04 pm
Senti Bio Highlights Initial Gene Circuit Data From Collaborations at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - May 20th, 2023 12:05 pm
Senti Bio Announces First Quarter 2023 Results and Pipeline Updates - May 9th, 2023 8:05 pm
Senti Bio Announces Multiple Data Presentations at the American Society of Gene and Cell Therapy 2023 Annual Meeting - May 2nd, 2023 8:45 pm
Senti Bio Highlights Preclinical Data from Multiple Gene Circuit Enabled Cell Therapy Programs at Annual AACR Meeting - Apr 17th, 2023 12:45 pm
Senti Bio to Participate in Upcoming Investor Conferences - Apr 14th, 2023 1:00 pm
Senti Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Reviews Recent Highlights - Mar 22nd, 2023 9:09 pm
Senti Bio Announces Three Preclinical Data Presentations from Gene Circuit-Enhanced CAR-NK Cell Oncology Pipeline at Annual AACR Meeting - Mar 14th, 2023 8:35 pm
Investors in Senti Biosciences (NASDAQ:SNTI) have unfortunately lost 82% over the last year - Feb 6th, 2023 11:26 am
Senti Biosciences Announces New Employment Inducement Grants - Feb 3rd, 2023 9:05 pm
Senti Bio to Present at the SVB Securities Global Biopharma Conference - Feb 1st, 2023 9:05 pm
Senti Bio Announces Pipeline Prioritization to Focus on Logic Gated Cell Therapies; Updates Cash Runway Guidance - Jan 27th, 2023 1:00 pm
We Think Senti Biosciences (NASDAQ:SNTI) Needs To Drive Business Growth Carefully - Dec 27th, 2022 11:53 am
Senti Bio to Present at 41st Annual J.P. Morgan Healthcare Conference - Dec 19th, 2022 12:55 pm
Senti Bio Highlights Preclinical Data from Logic-Gated Gene Circuit CAR-NK Cell Therapy SENTI-202 at ASH Annual Meeting and Investor Event - Dec 11th, 2022 2:00 pm
Senti Bio to Host Investor Event Highlighting SENTI-202 at the 2022 ASH Annual Meeting - Nov 23rd, 2022 12:55 pm
Senti Biosciences Third Quarter 2022 Earnings: Beats Expectations - Nov 16th, 2022 11:16 am
Senti Bio Reports Third Quarter Financial Results and Pipeline Updates - Nov 10th, 2022 12:55 pm
Senti Bio to Present Preclinical Data for SENTI-202 at the 2022 ASH Annual Meeting - Nov 3rd, 2022 1:05 pm
Senti Bio Announces New Employment Inducement Grants - Oct 28th, 2022 8:05 pm